ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.423,28
0,05%
S&P 500
6.084,19
0,82%
Dow Jones
44.148,56
-0,22%
Euro vs US Dollar
1,05145
0,08%
Bitcoin
100.874,30
-0,32%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) News

IRWD

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IRWD
DatumZeitQuelleÜberschriftSymbolFirma
05/12/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
26/11/202422h01Business WireIronwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
20/11/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
20/11/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
15/11/202422h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
15/11/202422h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
14/11/202421h31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IRWDIronwood Pharmaceuticals Inc
13/11/202422h01Business WireIronwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
12/11/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/11/202423h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
07/11/202413h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/11/202413h00Business WireIronwood Pharmaceuticals Reports Third Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
28/10/202412h00Business WireOnce-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024NASDAQ:IRWDIronwood Pharmaceuticals Inc
24/10/202422h00Business WireIronwood Pharmaceuticals to Host Third Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
23/10/202423h04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
30/09/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
29/08/202422h01Business WireIronwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
14/08/202423h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
14/08/202423h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/08/202422h05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/202413h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/202413h00Business WireIronwood Pharmaceuticals Reports Second Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
25/07/202422h00Business WireIronwood Pharmaceuticals to Host Second Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
12/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
10/06/202422h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
10/06/202422h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/06/202419h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/06/202421h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
30/05/202422h01Business WireIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IRWD

Kürzlich von Ihnen besucht

BIT
UC4AYV
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten